Novel CSF tau biomarkers can be used for disease staging of sporadic Alzheimer’s

JSON

Salvadó G, Horie K, Barthélemy NR, Vogel JW, Binette AP, Chen CD, Gordon BA, Benzinger TLS, Holtzman DM, Morris JC, Palmqvist S, Stomrud E, Janelidze S, Ossenkoppele R, Schindler SE, Bateman RJ, Hansson O

Alzheimers Dement 19 (S14) - [2023-12-00; online 2023-12-25]

DOI 10.1002/alz.075367

Crossref 10.1002/alz.075367